Celestial Biolabs Ltd. announced unaudited standalone earnings results for the second quarter and half year ended September 30, 2016. For the quarter, the company reported sales/income from operations of INR 79.183 million compared to INR 84.914 million reported a year ago. Profit from operations before other income, finance costs and exceptional items was INR 6.875 million compared to INR 10.141 million reported a year ago. Profit from ordinary activities before tax was INR 6.875 million compared to INR 5.387 million reported a year ago. Net profit was INR 5.565 million or INR 0.25 per basic and diluted share before and after extraordinary items compared to INR 4.390 million or INR 0.24 per basic and diluted share before and after extraordinary items reported a year ago. For the half year, the company reported sales/income from operations of INR 180.276 million compared to INR 165.175 million reported a year ago. Profit from operations before other income, finance costs and exceptional items was INR 13.234 million compared to INR 19.734 million reported a year ago. Profit from ordinary activities before tax was INR 13.233 million compared to INR 10.093 million reported a year ago. Net profit was INR 10.712 million or INR 0.28 per basic and diluted share before and after extraordinary items compared to INR 8.225 million or INR 0.44 per basic and diluted share before and after extraordinary items reported a year ago.